Department of Anaesthesia, Centre of Head and Orthopaedics, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Department of Anaesthesia, Centre of Juliane Marie, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Acta Anaesthesiol Scand. 2020 Sep;64(8):1082-1088. doi: 10.1111/aas.13645. Epub 2020 Jun 18.
The number of elderly is increasing, and a large proportion of these people will require surgery and anaesthesia. However, little data exist regarding rocuronium in patients above 80 years of age. The aim of this study was to determine the onset time and duration of action for rocuronium 0.6 mg/kg in patients above 80 years compared with young adults.
This prospective observational study included 16 young (18-40 years) and 16 elderly (>80 years) patients scheduled for total intravenous anaesthesia. Neuromuscular block following rocuronium 0.6 mg/kg was monitored with acceleromyography using train-of-four (TOF) stimulation. The primary outcome was onset time (from administration of rocuronium until TOF count = 0). Secondary outcomes were duration of action (from administration to TOF ratio >0.9) and intubating conditions according to Intubation Difficulty Score.
Elderly patients, median age of 84 years, had significantly prolonged onset time compared to younger patients; median 135 seconds (135-158) vs 90 seconds (90-105), respectively, a mean difference of 82 seconds (40-124) and Wilcoxon Mann-Whitney odds (WMW) of 19.48 (7.48-X). Duration of action in elderly patients was significantly longer, with a median time of 81 minute (71-97) vs 53 minute (42-73), respectively, a mean difference of 31 minute (14-48), and WMW odds of 6.35 (2.59-X). There was no significant difference in intubating conditions.
Patients above 80 years had significantly prolonged onset time and duration of action after rocuronium 0.6 mg/kg compared with patients aged 18-40 years.
随着人口老龄化,需要手术和麻醉的老年人数量越来越多。然而,目前关于 80 岁以上人群罗库溴铵的资料很少。本研究旨在比较 80 岁以上患者和年轻患者接受 0.6mg/kg 罗库溴铵时起效时间和作用持续时间。
这是一项前瞻性观察研究,纳入了 16 名年轻(18-40 岁)和 16 名老年(>80 岁)择期全身静脉麻醉患者。使用肌电图监测罗库溴铵 0.6mg/kg 后的神经肌肉阻滞,采用四成串刺激(TOF)。主要结局是起效时间(从给予罗库溴铵到 TOF 计数=0)。次要结局是作用持续时间(从给予药物到 TOF 比值>0.9)和根据插管困难评分的插管条件。
老年患者中位年龄 84 岁,与年轻患者相比,起效时间显著延长;中位数分别为 135 秒(135-158)和 90 秒(90-105),平均差为 82 秒(40-124),Wilcoxon-Mann-Whitney 比值(WMW)为 19.48(7.48-X)。老年患者的作用持续时间明显延长,中位数为 81 分钟(71-97)和 53 分钟(42-73),平均差为 31 分钟(14-48),WMW 比值为 6.35(2.59-X)。插管条件无显著差异。
与 18-40 岁的患者相比,接受 0.6mg/kg 罗库溴铵的 80 岁以上患者起效时间和作用持续时间显著延长。